The levels of resistance to commonly used protease and reverse transcriptase inhibitors.
- Min Chen (147733)
- Yanling Ma (169386)
- Yingzhen Su (394770)
- Li Yang (6520)
- Renzhong Zhang (516414)
- Chaojun Yang (394771)
- Huichao Chen (394773)
- Wenyun Yan (379492)
- Yuhua Shi (379491)
- Lijuan Dong (516415)
- Ling Chen (25698)
- Manhong Jia (379490)
- Lin Lu (5759)
Publication date
January 2014
DOIAbstract
<p>PIs: protease inhibitors; NRTIs: nucleoside reverse transcriptase inhibitors; NNRTIs: non-nucleoside reverse transcriptase inhibitors;</p><p>ATV: atazanavir; DRV: darunavir; FPV: fosamprenavir; IDV: indinavir; LPV: lopinavir; NFV: nelfinavir; SQV: saquinavir; TPV: tipranavir; 3TC: lamivudine; ABC: abacavir; AZT: zidovudine; D4T: stavudine; DDI: didanosine; FTC: emtricitabine; TDF: tenofovir; EFV: efavirenz; ETR: etravirine; NVP: nevirapine; RPV: rilpivirine.</p><p>S: Susceptible; P: Potential low-level resistance; L: Low-level resistance; I: Intermediate resistance; H: High-level resistance.</p
Add to ORKG